| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |